KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Accounts Payables (2016 - 2025)

Teladoc Health (TDOC) has disclosed Accounts Payables for 12 consecutive years, with $48.0 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 44.78% to $48.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $48.0 million through Dec 2025, up 44.78% year-over-year, with the annual reading at $48.0 million for FY2025, 44.78% up from the prior year.
  • Accounts Payables hit $48.0 million in Q4 2025 for Teladoc Health, down from $52.2 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $94.4 million in Q2 2022 to a low of $16.1 million in Q2 2023.
  • Historically, Accounts Payables has averaged $45.7 million across 5 years, with a median of $45.4 million in 2021.
  • Biggest five-year swings in Accounts Payables: skyrocketed 322.22% in 2021 and later crashed 82.97% in 2023.
  • Year by year, Accounts Payables stood at $47.3 million in 2021, then increased by 0.92% to $47.7 million in 2022, then fell by 8.5% to $43.6 million in 2023, then dropped by 24.08% to $33.1 million in 2024, then surged by 44.78% to $48.0 million in 2025.
  • Business Quant data shows Accounts Payables for TDOC at $48.0 million in Q4 2025, $52.2 million in Q3 2025, and $54.4 million in Q2 2025.